办公地址：广州市海珠区新港东路 69 号丸美大厦 11 楼 邮政编码：510308 证券代码：603983 证券简称：丸美生物 公告编号：2025-024 广东丸美生物技术股份有限公司 关于变更办公地址的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 广东丸美生物技术股份有限公司（以下简称"公司"）已于近日搬迁至新办 公地址，具体情况如下： | 变更事项 | 变更前 | | | | | 变更后 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 办公地址 | 广州市天河区珠江新城冼村路 | | | | 广州市海珠区新港东路 | | 69 号丸美 | | | 11 | 号保利威座大厦南塔 | 6 楼 | 大厦 11 | 楼 | | | | 邮政编码 | | 510623 | | | | 510308 | | 除上述变更内容外，公司投资者联系电话、电子邮箱等其他联系方式均保持 不变，具体如下： 投资者联系电话：020-66378685 传真号码：020-663 ...

证券代码：603983 证券简称：丸美生物 公告编号：2025-025 广东丸美生物技术股份有限公司 关于召开2025年第一次临时股东大会的通知 股东大会召开日期：2025年9月19日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 一、 召开会议的基本情况 (一) 股东大会类型和届次 2025年第一次临时股东大会 (二) 股东大会召集人：董事会 (三) 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票 相结合的方式 (四) 现场会议召开的日期、时间和地点 召开的日期时间：2025 年 9 月 19 日 15 点 00 分 召开地点：广州市海珠区新港东路 69 号丸美大厦 11 楼会议室 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者的投 票，应按照《上海证券交易所上市公司自律监管指引第 1 号-规范运作》等有关 规定执行。 (七) 涉及公开征集股东投票权 无。 二、 会议审议事项 本次股东大会审议议案及投票股东类型 ...

Group 1 - The cosmetics sector increased by 0.56% on September 1, with Lafang Jiahua leading the gains [1] - The Shanghai Composite Index closed at 3875.53, up 0.46%, while the Shenzhen Component Index closed at 12828.95, up 1.05% [1] - Lafang Jiahua's stock price rose by 9.99% to 26.97, with a trading volume of 114,000 shares and a transaction value of 300 million yuan [1] Group 2 - The cosmetics sector saw a net inflow of 15.558 million yuan from institutional investors, while retail investors contributed a net inflow of 45.296 million yuan [2] - Major stocks in the sector experienced varied capital flows, with Lafang Jiahua having a net inflow of 75.247 million yuan from institutional investors [3] - Other companies like Jiahen Jiahua and Huaye Fragrance also saw significant net inflows, while stocks like Marubi Biological and Shanghai Jahwa experienced net outflows from institutional and retail investors [3]

Group 1 - The cosmetics sector increased by 1.05% on August 29, with Jiaheng Jiahua leading the gains [1] - The Shanghai Composite Index closed at 3857.93, up 0.37%, while the Shenzhen Component Index closed at 12696.15, up 0.99% [1] - Jiaheng Jiahua's stock price rose by 20.01% to 31.85, with a trading volume of 138,900 shares and a transaction value of 434 million yuan [1] Group 2 - The cosmetics sector saw a net inflow of 10.35 million yuan from institutional investors, while retail investors contributed a net inflow of 88.15 million yuan [2] - Major stocks in the sector experienced varied capital flows, with Jiaheng Jiahua having a net inflow of 76.21 million yuan from institutional investors [3] - Shanghai Jiahua had a net inflow of 35.86 million yuan from institutional investors, but a net outflow of 51.01 million yuan from retail investors [3]

Group 1: AI Industry Insights - The report highlights the release of the "Artificial Intelligence+" action plan by the State Council, which aims to strengthen foundational support capabilities in AI, including innovation in AI chips and software ecosystem development [3] - The action plan is expected to provide long-term institutional guarantees for the development of the AI industry, addressing current bottlenecks such as insufficient computing power and low-quality data supply [3] - Companies to watch include those involved in AI technology and applications, such as Kingdee International, Meituan, and various players in AI education and healthcare [3] Group 2: Economic and Market Outlook - The "14th Five-Year Plan" emphasizes the need for a unified market to break local protectionism and promote efficient resource allocation [4] - The plan also aims to support consumer spending and upgrade consumption structures, indicating a shift in fiscal spending towards improving livelihoods [4] - The capital market reform during this period is expected to transition from policy-driven to institution-driven, promoting high-quality development of the capital market [4] Group 3: Aerospace Industry Developments - China's commercial aircraft market share exceeds 20%, with the C919 aircraft production capacity expanding, potentially breaking the Airbus and Boeing duopoly [4] - The demand for commercial engines in China is projected to exceed $600 billion over the next 20 years, with an average annual demand of over 200 billion RMB [4] - The report indicates that the domestic aerospace industry is likely to experience significant growth due to the focus on local market development and self-sufficiency [4] Group 4: Semiconductor Sector Performance - Changdian Technology reported a revenue of 18.605 billion RMB for the first half of 2025, reflecting a year-on-year growth of 20.14%, driven by increased domestic orders and market demand recovery [8][34] - The company's net profit decreased by 23.98% due to ongoing construction of new factories and rising financial costs, but gross margin improved from 12.6% to 14.3% [34][38] - The semiconductor industry is experiencing a recovery, with global sales expected to continue growing, providing opportunities for companies in this sector [36] Group 5: Consumer Electronics and Home Appliances - Wanhe Electric reported a revenue of 4.08 billion RMB in the first half of 2025, with overseas revenue growing by 26.5% while domestic revenue declined by 4.4% [16] - The company is focusing on digital transformation and cost optimization to enhance its competitiveness in both domestic and international markets [16] - The report anticipates steady growth in the home appliance sector, driven by innovations and expansion into overseas markets [16] Group 6: Automotive and New Energy Sectors - Tuhu-W reported a revenue of 7.877 billion RMB in the first half of 2025, with a year-on-year growth of 10.54%, driven by expansion into lower-tier cities [17] - The company is enhancing its supply chain and logistics efficiency, which has positively impacted its operational performance [17] - The new energy vehicle segment is emerging as a significant growth driver, with a notable increase in transaction users on the platform [17]

证券研究报告 交运 东莞控股(000828.SZ)点评：高速公路主业稳固，2025-2027 年分红收益可观： 公司 2025H1 实现收入约 7.66 亿元，同比-8.57%，归母净利润约 5.32 亿元，同比 +20.51%；其中 2025 年 Q2 实现收入 4.00 亿元，同比-6.28%，归母净利润 3.13 亿元，同比+699.24%。公司发布 2025 中期分红公告，公司拟向全体股东派发现金 红利 0.15 元/股（含税）。高速公路主业稳固，类金融业务收缩致收入承压。毛利率 变化主因收入结构调整，冲回计提损失助力业绩提升。改扩建稳步推进，新能源业 务网络快速扩张。公司高速主业优势夯实，多元化布局初见成效，高分红承诺稳定 股东收益，2028 年莞深高速改扩建结束后有望释放盈利增量。 晨会 hyzqdatemark 2025 年 08 月 27 日 投资要点： 资料来源：聚源，华源证券研究所，截至2025年08月27日 华源晨会精粹 20250827 新消费 丸美生物(603983.SH)点评：25H1 收入端高增，主品牌丸美势能向好：公司 25H1 实现总营业收入 17.69 亿元，同比增长 30 ...

[Table_Title] 研究报告 Research Report 27 Aug 2025 丸美股份 Guangdong Marubi Biotechnology (603983 CH) 25Q2 市场投入加大，矩阵化运营构建多个大单品 25Q2: Increased Market Investment, Launch Multiple Major Products through Matrix Operation 寇媛媛 Yuanyuan Kou 吴颖婕 Mindy Wu yy.kou@htisec.com mindy.yj.wu@htisec.com [Table_yemei1] 热点速评 Flash Analysis [Table_summary] (Please see APPENDIX 1 for English summary) 事件：丸美生物发布 25H1 业绩报告并举行业绩会。 25H1 丸美在品牌建设、渠道拓展等多领域持续发力，推动业绩稳健增长。公司 25H1 实现营收 17.69 亿元，同比增 长 30.83%，这一增长主要得益于品牌创新、渠道拓展以及运营效率提升等多方面的持续发力。公司 ...

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected stock price increase of over 15% compared to the benchmark index [4]. Core Insights - The company reported a revenue of 1.769 billion yuan for H1 2025, representing a year-on-year growth of 30.83%. The net profit attributable to the parent company was 186 million yuan, up 5.21% year-on-year, while the net profit excluding non-recurring items was 177 million yuan, reflecting a 6.64% increase [1]. - The gross margin for H1 2025 was 74.6%, remaining stable year-on-year, while the net margin decreased by 2.58 percentage points to 10.52% due to increased sales expenses [1]. - The company is focusing on a big product strategy, enhancing penetration through key products and new launches, which has contributed to revenue growth [2]. Revenue and Profitability - The company's online channel revenue reached 1.571 billion yuan in H1 2025, accounting for 88.87% of total revenue, with a year-on-year growth of 37.85%. The offline channel revenue was 197 million yuan, down 7.07% [3]. - The report forecasts EPS for 2025, 2026, and 2027 to be 1.14 yuan, 1.45 yuan, and 1.77 yuan respectively, with corresponding P/E ratios of 37, 29, and 24 [4]. Brand and Market Strategy - The main brand, Marubi, is focusing on four key products and three major sets to enhance market penetration, while the PL brand, Lianhuo, is leveraging limited edition products to strengthen user engagement and expand its market [2]. - The company is actively enhancing its online presence through multi-channel operations and has seen significant growth in member transactions and live-stream sales [3].

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | --- | | 300955 | 嘉亨家化 | 25.03 | 2.08% | | 19.51万 | | 4.98亿 | | 603983 | 丸美生物 | 40.94 | -2.13% | | 6.04万 | | 2.52亿 | | 300740 | 水羊股份 | 23.07 | -3.07% | | 40.75万 | | 9.57亿 | | 300849 | 锦盛新材 | 13.08 | -3.18% | | 4.79万 | | 6366.17万 | | 600223 | 福瑞达 | 8.23 | -3.29% | | 23.11万 | | 1.93亿 | | 002094 | 青岛金王 | 8.75 | -3.31% | | 75.07万 | | 6.68亿 | | 600315 | 上海家化 | 25.47 | -3.34% | | 15.29万 | | 3.96亿 | | 300957 | 贝泰妮 | 46.96 | -3 ...

Group 1 - The core viewpoint of the news is that brokerage ratings are crucial for investors, with nearly 200 A-share listed companies receiving "buy" ratings on August 27, focusing on industries such as software development, chemical pharmaceuticals, gaming, chemical raw materials, beauty care, home appliances, and liquor [1][4]. Group 2 - Kingsoft Office received significant attention from brokerages, with eight reports in the past month, ranking first among stocks promoted by brokerages on August 27. The report from Cinda Securities highlighted a noticeable recovery in revenue growth and the positive impact of AI on efficiency [4][5]. - East China Pharmaceutical also garnered attention, with eight brokerage reports in the past month. Southwest Securities projected EPS for 2025-2027 to be 2.31 yuan, 2.48 yuan, and 2.71 yuan, maintaining a "buy" rating [4][5]. - Gigabit received multiple brokerage reports, indicating strong performance and growth potential in the gaming sector [4][5]. - Other companies such as Hualu Hengsheng, Marubi Biotechnology, Hisense Visual, Huadian Co., Ltd., Jianshiyuan, Poly Development, and Tongli Co., Ltd. also received attention from various brokerages in the past month [5].